American International Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,160
| Closed | -$76.2K | – | 2999 |
|
|
2024
Q1 | $76.2K | Sell |
5,160
-44
| -0.8% | -$618 | ﹤0.01% | 2655 |
|
|
2023
Q4 | $69.8K | Sell |
5,204
-21
| -0.4% | -$265 | ﹤0.01% | 2727 |
|
|
2023
Q3 | $64.4K | Buy |
5,225
+186
| +4% | +$2.25K | ﹤0.01% | 2748 |
|
|
2023
Q2 | $62K | Buy |
+5,039
| New | +$63K | ﹤0.01% | 2824 |
|
|
2018
Q2 | – | Sell |
-10,425
| Closed | -$66K | – | 3204 |
|
|
2018
Q1 | $66K | Sell |
10,425
-562
| -5% | -$4.65K | ﹤0.01% | 2828 |
|
|
2017
Q4 | $89K | Buy |
10,987
+55
| +0.5% | +$513 | ﹤0.01% | 2782 |
|
|
2017
Q3 | $125K | Buy |
10,932
+815
| +8% | +$8.57K | ﹤0.01% | 2536 |
|
|
2017
Q2 | $99K | Buy |
10,117
+564
| +6% | +$11.5K | ﹤0.01% | 2731 |
|
|
2017
Q1 | $231K | Buy |
9,553
+633
| +7% | +$15.8K | ﹤0.01% | 2093 |
|
|
2016
Q4 | $286K | Sell |
8,920
-23
| -0.3% | -$981 | ﹤0.01% | 1962 |
|
|
2016
Q3 | $447K | Buy |
8,943
+13
| +0.1% | +$540 | ﹤0.01% | 1680 |
|
|
2016
Q2 | $379K | Buy |
8,930
+740
| +9% | +$40.3K | ﹤0.01% | 1749 |
|
|
2016
Q1 | $539K | Hold |
8,190
| – | – | ﹤0.01% | 1960 |
|
|
2015
Q4 | $509K | Sell |
8,190
-15
| -0.2% | -$1.05K | ﹤0.01% | 2021 |
|
|
2015
Q3 | $549K | Buy |
8,205
+10
| +0.1% | +$816 | ﹤0.01% | 1941 |
|
|
2015
Q2 | $797K | Buy |
8,195
+349
| +4% | +$33.2K | ﹤0.01% | 1771 |
|
|
2015
Q1 | $733K | Hold |
7,846
| – | – | ﹤0.01% | 1859 |
|
|
2014
Q4 | $698K | Sell |
7,846
-463
| -6% | -$33.7K | ﹤0.01% | 1856 |
|
|
2014
Q3 | $574K | Buy |
8,309
+146
| +2% | +$7.8K | ﹤0.01% | 2012 |
|
|
2014
Q2 | $468K | Sell |
8,163
-315
| -4% | -$16K | ﹤0.01% | 2232 |
|
|
2014
Q1 | $336K | Buy |
8,478
+200
| +2% | +$8.56K | ﹤0.01% | 2387 |
|
|
2013
Q4 | $348K | Buy |
8,278
+409
| +5% | +$11.9K | ﹤0.01% | 2299 |
|
|
2013
Q3 | $235K | Buy |
7,869
+6,538
| +491% | +$229K | ﹤0.01% | 2581 |
|
|
2013
Q2 | $70.5K | Buy |
+1,331
| New | +$58.3K | ﹤0.01% | 3386 |
|
Other funds holding MACK
RA
JC
American International Group's MACK Position: Q2 2024 in Review
American International Group sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2024, closing a stake of 5,160 shares — an estimated $76.2K sold.
American International Group first reported a position in MACK in Q2 2013 and held it in 24 quarters. The position peaked at $797K in Q2 2015. 12 funds tracked by Wall St. Rank hold MACK as of Q2 2024.
- American International Group reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
- American International Group sold 5,160 Merrimack Pharmaceuticals, Inc. shares in Q2 2024, an estimated $76.2K.
- American International Group first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 24 quarters.
- American International Group's Merrimack Pharmaceuticals, Inc. position peaked at $797K in Q2 2015.
- 12 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.